Anti-viral agents that activate RNase L

Details for Australian Patent Application No. 2007243403 (hide)

Owner The Cleveland Clinic Foundation Northern Arizona University

Inventors Torrence, Paul; Silverman, Robert; Francom, Paula; Jha, Babal Kant

Agent Davies Collison Cave

Pub. Number AU-A-2007243403

PCT Pub. Number WO2007/127212

Priority 60/795,069 25.04.06 US

Filing date 25 April 2007

Wipo publication date 8 November 2007

International Classifications

A61K 31/381 (2006.01) - having five-membered rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 31/12 (2006.01) Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

C07D 333/36 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

C07D 333/38 (2006.01) Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom

Event Publications

11 December 2008 PCT application entered the National Phase

  PCT publication WO2007/127212 Priority application(s): WO2007/127212

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2007243411-Elastomeric article with wireless micro and nano sensor system

2007243402-Fungicidal compositions and methods of using the same